Earlier diagnosis and earlier treatment of COPD in primary care

被引:70
作者
Price, David [1 ]
Freeman, Daryl
Cleland, Jen
Kaplan, Alan [2 ]
Cerasoli, Frank [3 ]
机构
[1] Univ Aberdeen, Ctr Acad Primary Care, Foresterhill Hlth Ctr, Aberdeen AB25 2AY, Scotland
[2] Family Phys Airways Grp Canada, Richmond Hill, ON, Canada
[3] Pfizer Inc, New York, NY USA
来源
PRIMARY CARE RESPIRATORY JOURNAL | 2011年 / 20卷 / 01期
关键词
COPD; early diagnosis; early treatment; primary care; OBSTRUCTIVE PULMONARY-DISEASE; SYMPTOM-BASED QUESTIONNAIRE; RANDOMIZED CONTROLLED-TRIAL; LUNG-FUNCTION DECLINE; GENERAL-PRACTICE; INHALED BUDESONIDE; SMOKING-CESSATION; IDENTIFYING COPD; DIMCA PROGRAM; AIR-FLOW;
D O I
10.4104/pcrj.2010.00060
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Chronic obstructive pulmonary disease (COPD) is a progressive disease that begins many years before a diagnosis is usually made. The need for an early and confirmed diagnosis of COPD is increasingly appreciated by primary care physicians in whose hands the ability to make improvements in early diagnosis largely rests. Case-finding of patients with symptoms of lifestyle limitation is probably the most practical way to achieve early diagnosis. Evidence suggests a burden of early COPD on afflicted people and their families. Early encouragement of smoking cessation, in conjunction with management of symptoms and treating activity limitation and exacerbations by appropriate non-pharmacologic and pharmacologic management at the earliest possible stage, could positively affect the impact and progression of the disease. (C) 2011 Primary Care Respiratory Society UK. All rights reserved. Q Zhang et al. Prim Care Respir J 2011; 20(1): 97-101 doi:10.4104/pcrj.2010.00061
引用
收藏
页码:15 / 22
页数:8
相关论文
共 74 条
[1]   The costs of exacerbations in chronic obstructive pulmonary disease (COPD) [J].
Andersson, F ;
Borg, S ;
Jansson, SA ;
Jonsson, AC ;
Ericsson, Å ;
Prütz, C ;
Rönmark, E ;
Lundbäck, B .
RESPIRATORY MEDICINE, 2002, 96 (09) :700-708
[2]  
[Anonymous], 2016, Fact Sheet
[3]   Smoking and lung function of lung health study participants after 11 years [J].
Anthonisen, NR ;
Connett, JE ;
Murray, RP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (05) :675-679
[4]   Smoking, lung function, and mortality [J].
Anthonisen, NR .
THORAX, 2000, 55 (09) :729-730
[5]  
Beeh K M, 2006, Pneumologie, V60, P341, DOI 10.1055/s-2005-919145
[6]  
Bridevaux PO, 2008, THORAX, V63, P768, DOI 10.1136/thx.2007.093724
[7]   Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J].
Burge, PS ;
Calverley, PMA ;
Jones, PW ;
Spencer, S ;
Anderson, JA ;
Maslen, TK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1297-1303
[8]  
Calverley Peter M A, 2005, COPD, V2, P225
[9]   Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD [J].
Casaburi, R ;
Kukafka, D ;
Cooper, CB ;
Witek, TJ ;
Kesten, S .
CHEST, 2005, 127 (03) :809-817
[10]   Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease - Results from the TORCH study [J].
Celli, Bartolome R. ;
Thomas, Nicola E. ;
Anderson, Julie A. ;
Ferguson, Gary T. ;
Jenkins, Christine R. ;
Jones, Paul W. ;
Vestbo, Jorgen ;
Knobil, Katharine ;
Yates, Julie C. ;
Calverley, Peter M. A. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (04) :332-338